These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30244146)

  • 41. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
    Pilcer G; Vanderbist F; Amighi K
    J Pharm Sci; 2009 Apr; 98(4):1463-75. PubMed ID: 18752304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein spheres prepared by drop jet freeze drying.
    Eggerstedt SN; Dietzel M; Sommerfeld M; Süverkrüp R; Lamprecht A
    Int J Pharm; 2012 Nov; 438(1-2):160-6. PubMed ID: 22960322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thermal ink-jet spray freeze-drying for preparation of excipient-free salbutamol sulphate for inhalation.
    Mueannoom W; Srisongphan A; Taylor KM; Hauschild S; Gaisford S
    Eur J Pharm Biopharm; 2012 Jan; 80(1):149-55. PubMed ID: 22001519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy.
    Li HY; Neill H; Innocent R; Seville P; Williamson I; Birchall JC
    J Drug Target; 2003 Aug; 11(7):425-32. PubMed ID: 15203931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery.
    Wang JL; Hanafy MS; Xu H; Leal J; Zhai Y; Ghosh D; Williams Iii RO; David Charles Smyth H; Cui Z
    Int J Pharm; 2021 Mar; 596():120215. PubMed ID: 33486021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
    Tang P; Chan HK; Chiou H; Ogawa K; Jones MD; Adi H; Buckton G; Prud'homme RK; Raper JA
    Int J Pharm; 2009 Feb; 367(1-2):51-7. PubMed ID: 18848874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spray-freeze-drying of nanosuspensions: the manufacture of insulin particles for needle-free ballistic powder delivery.
    Schiffter H; Condliffe J; Vonhoff S
    J R Soc Interface; 2010 Aug; 7 Suppl 4(Suppl 4):S483-500. PubMed ID: 20519207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
    Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
    Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.
    Seville PC; Kellaway IW; Birchall JC
    J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.
    Liang W; Kwok PC; Chow MY; Tang P; Mason AJ; Chan HK; Lam JK
    Eur J Pharm Biopharm; 2014 Jan; 86(1):64-73. PubMed ID: 23702276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.
    Otake H; Okuda T; Hira D; Kojima H; Shimada Y; Okamoto H
    Pharm Res; 2016 Apr; 33(4):922-31. PubMed ID: 26643921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spray freeze-drying for inhalation application: process and formulation variables.
    Rostamnezhad M; Jafari H; Moradikhah F; Bahrainian S; Faghihi H; Khalvati R; Bafkary R; Vatanara A
    Pharm Dev Technol; 2022 Mar; 27(3):251-267. PubMed ID: 34935582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developing spray-freeze-dried particles containing a hyaluronic acid-coated liposome-protamine-DNA complex for pulmonary inhalation.
    Fukushige K; Tagami T; Naito M; Goto E; Hirai S; Hatayama N; Yokota H; Yasui T; Baba Y; Ozeki T
    Int J Pharm; 2020 Jun; 583():119338. PubMed ID: 32311468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.
    Leng D; Kissi EO; Löbmann K; Thanki K; Fattal E; Rades T; Foged C; Yang M
    AAPS PharmSciTech; 2019 Mar; 20(3):137. PubMed ID: 30847607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bovine serum albumin as a lyoprotectant for preparation of DNA dry powder formulations using the spray-freeze drying method.
    Tsukamoto M; Okuda T; Okamoto H; Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Biol Pharm Bull; 2012; 35(7):1178-81. PubMed ID: 22791169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.
    Maa YF; Ameri M; Shu C; Payne LG; Chen D
    J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.
    Seto Y; Suzuki G; Leung SS; Chan HK; Onoue S
    Pharm Res; 2016 Jun; 33(6):1447-55. PubMed ID: 26975360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.